Sigma Healthcare

Last updated

Sigma Healthcare Limited
Company type Public
ASX:  SIG
IndustryPharmaceuticals
Founded1912 in Melbourne, Australia
Headquarters Clayton, Victoria, Australia
Area served
Australia
Key people
Michael Sammells (Chairman)
Vikesh Ramsunder (CEO & Managing Director)
ProductsPrescription, over-the-counter and generic pharmaceutical products
RevenueIncrease2.svgA$3.66 billion (2023)
Increase2.svgA$49.6 million (2023)
Number of employees
1200
Subsidiaries Amcal
Discount Drug Stores
Pharmasave Australia
Guardian Pharmacy
Central Healthcare Services
MPS
NostraData Pty Ltd (51% owned)
Website sigmahealthcare.com.au

Sigma Healthcare Limited is an Australian, ASX-listed company with a focus on the pharmacy industry. [1] The company has pharmacy operations in retail, wholesale and distribution. From its head office in Clayton, Victoria, Sigma manages over 1,200 branded and independent pharmacies. Sigma Healthcare owns Australian retail pharmacy brands: Amcal, Discount Drug Stores and Guardian Pharmacy. The company also has a presence in the hospital pharmacy services, contract logistics, dose administration aids and other healthcare service adjacencies.

Contents

History

Sigma Co. Ltd was established in Melbourne in 1912, by Ernest Leete and Thomas Church, with the endorsement of the South Suburban Chemists’ Association. The impetus for such a move was driven by the high costs of wholesale drugs and medicines at the time, and Leete and Church set about manufacturing their own products for sale exclusively by members of the association. Established as a company to be funded by member subscriptions, initial interest from pharmacists was lukewarm, however Leete and Church persisted with their manufacturing plans. By the end of the first year however, the venture had attracted over two hundred subscribers, who agreed to the formation of a company owned by shareholders.

Sigma Company Limited was formally registered on 13 October 1913.

Over the course of the next 80 years, Sigma continued to expand its operations and develop into new markets, including exports into the Asia-Pacific and the Middle East. By 1992, Sigma owned assets of $180 million, saw group sales turnover of $600 million and employed more than a thousand people. [2]

By the end of the 20th century, Sigma had purchased the Guardian and Amcal retail pharmacy brands, and in 1999 listed on the Australian Stock Exchange as Sigma Pharmaceuticals Limited.

On 3 May 2017, Sigma board of directors and shareholders voted on a change of name to Sigma Healthcare Limited. The now-publicly listed company also changed its ASX ticker from SIP to SIG at this time. [3]

In December 2023, Chemist Warehouse Group announced its intention to merge with Sigma Healthcare through a reverse takeover. [4]

Mergers and acquisitions

In 2010, Sigma Pharmaceutical restructured and sold its generic drug manufacturing business to South Africa’s Aspen Pharmacare for AUD$804 million, ending an almost 100-year legacy in the manufacturing field for the company. The pharmaceuticals division included generic brands, over-the-counter medications, its Herron brand, ethical products, medical products and the manufacturing businesses. [5]

In March 2014, Sigma acquired the healthcare product wholesaler and distributor Central Healthcare Services in a deal worth $24.5 million. [6]

In September 2014, the company bought the Queensland-based Discount Drug Store (DDS) banner for $26.7 million. [7] The DDS acquisition was set to add 120 pharmacies under that brand to the Sigma network.

In 2017, partly in response to Australian Government changes pharmacists’ payments under the Pharmaceutical Benefits Scheme, Sigma diversified further, acquiring Medication Packaging Systems (MPS), Australia's largest provider of dose administration services to the aged care sector and community pharmacy patients.

During the 2020 COVID-19 pandemic, Sigma announced that it had sold the land and buildings of its distribution centres in Queensland and New South Wales, under an agreement to lease the facilities back from the new owners for an initial term of 15 years. [8]

The following year, Sigma launched a bid for Australian Pharmaceutical Industries, which owned a number of rival retail pharmacy brands including Priceline, Pharmacist Advice and Soul Pattinson Chemists. [9] The proposed merger, valued at AUD$773.5 million, was however withdrawn on 5 October 2021, [10] with Australian retail conglomerate Wesfarmers, announcing its purchase of 19.3% of API’s shares of API two days later. [11] On 11 February 2022, the ACCC announced that it will not oppose the proposed acquisition of API by Wesfarmers. [12]

In September 2022 Sigma announced that it planned to consolidate its retail brands and focus franchise growth under the Amcal and Discount Drug Store brands. [13]

Financial performance

The Group reported net profit after tax (NPAT) attributable to owners of the company for the year ended 31 January 2021 of $59,761,000 which was up $72,091,000 from the prior period ($12,330,000 loss). Reported earnings before interest, tax, depreciation and amortisation (EBITDA) of $94,198,000 was up 289.2% on the prior period ($24,200,000). [14]

Controversies

In 2010, Sigma shares were placed in a trading halt on the Australian Stock Exchange – initially due to a profit warning. [15] Since then, allegations of accounting irregularities [16] and preferential deals negotiated with certain pharmacy chains (at the expense of smaller independent chemists) that left Sigma losing money at the expense of their own Amcal and Guardian Pharmacies banners [17] and forsaking cashflow emerged. [18] The trading halt was lifted later that year. The events resulted in the initiation of a shareholder class action before the Federal Court of Australia.

Related Research Articles

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist in Commonwealth English, is a healthcare professional who specializes in the preparation, dispensing, and management of medications. A pharmacist provides pharmaceutical advice and guidance, often serving as a primary care provider in the community, and offering other services, such as health screenings and immunizations.

Shoppers Drug Mart Inc., commonly known as Shoppers is a Canadian retail pharmacy chain based in Toronto, Ontario. It has more than 1,300 stores in ten provinces and two territories.

Coles Supermarkets Australia Pty Ltd, trading as Coles, is an Australian supermarket, retail and consumer services chain, headquartered in Melbourne as part of the Coles Group. Founded in 1914 in Collingwood by George Coles, Coles operates 846 supermarkets throughout Australia, including several now re-branded Bi-Lo Supermarkets. Coles has over 120,000 employees and accounts for around 27 per cent of the Australian market. Coles' large head office site in Melbourne's inner south-east has 4,000 employees of the workforce located inside.

McKesson Europe

McKesson Europe AG, with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year and is represented in 13 countries in Europe. In the 2019 financial year the company achieved a turnover of EUR 21.18 billion. The majority shareholder of the company is the US-based McKesson Corporation, which holds a share of 77.01%. The remaining 22.99% of shares are available on the open market. Kevin Kettler, a US citizen, has been Chairman of McKesson Europe since 1 November 2018.

Bunnings Group Limited, trading as Bunnings Warehouse or Bunnings, is an Australian household hardware and garden centre chain. The chain has been owned by Wesfarmers since 1994, and has stores in Australia and New Zealand.

<span class="mw-page-title-main">Wesfarmers</span> Australian conglomerate

Wesfarmers Limited is an Australian conglomerate, headquartered in Perth, Western Australia. It has interests predominantly in Australia and New Zealand, operating in retail, chemical, fertiliser, industrial and safety products. With revenue of A$43.5 billion in the 2023 financial year, it is one of Australia's largest companies by revenue. Wesfarmers is also one of the largest private employers in Australia, with approximately 107,000 employees.

<span class="mw-page-title-main">Alliance Boots</span> Pharmaceutical company

Alliance Boots was a multinational pharmacy-led health and beauty group with corporate headquarters in Bern, Switzerland and operational headquarters in Nottingham and Weybridge, United Kingdom.

<span class="mw-page-title-main">Priceline (Australia)</span> Australian health and beauty retailer owned by Wesfarmers

Priceline is an Australian health and beauty retailer. The Priceline brand has two store types; a traditional Priceline and Priceline Pharmacy. It is owned by Australian Pharmaceutical Industries, which was acquired by Wesfarmers in 2022.

McNeil Consumer Healthcare is an American medicals products company belonging to Kenvue consumer health group. It primarily sells fast-moving consumer goods such as over-the-counter drugs.

<span class="mw-page-title-main">Coles Group</span> Australian public company

Coles Group Limited is an Australian public company operating several retail chains. Its chief operations are primarily concerned with the sale of food and groceries through its flagship supermarket chain Coles Supermarkets, and the sale of liquor through its Coles Liquor outlets. Since its foundation in Collingwood, Victoria in 1914, Coles has grown to become the second-largest retailer in Australia after its principal rival, Woolworths, in terms of revenue.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's largest healthcare company, and its headquarters are in Woonsocket, Rhode Island. In 2023, the company was ranked 65th in the Forbes Global 2000.

Australian Pharmaceutical Industriea (API) is a health and beauty company owned by Wesfarmers. It is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. The company is involved in retailing through company-owned stores and franchise operations. API operates in the retail health and beauty industry under the following brands: Priceline, Priceline Pharmacy, Soul Pattinson and Pharmacist Advice.

<span class="mw-page-title-main">Pharmacy (shop)</span> Shop that provides pharmaceutical drugs

A pharmacy is a retail shop which provides pharmaceutical drugs, among other products. At the pharmacy, a pharmacist oversees the fulfillment of medical prescriptions and is available to counsel patients about prescription and over-the-counter drugs or about health problems and wellness issues. A typical pharmacy would be in the commercial area of a community.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. 

<span class="mw-page-title-main">Well Pharmacy</span> British pharmacy company

Well, formerly known as The Co-operative Pharmacy, is the second largest overall pharmacy chain after the company Boots in the United Kingdom. It is the largest pharmacy chain in Wales.

<span class="mw-page-title-main">Boots (company)</span> British multinational pharmacy store chain

Boots UK Limited, trading as Boots, is a health and beauty retailer and pharmacy chain that operates in the United Kingdom. It also operates internationally, including Ireland, Italy, Norway, the Netherlands, Malta, Thailand and Indonesia.

Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens bought the 55% stake in Alliance Boots that it did not already own. The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion. Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years. Walgreens became a subsidiary of the newly created company after the transactions were completed. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings of the largest United States corporations by total revenue.

<span class="mw-page-title-main">Chemist Warehouse</span> Australian multinational pharmacy retail company

Chemist Warehouse Group is an Australian company operating a chain of retail pharmacies both locally and internationally. The company is one of Australia's largest pharmacy retailers with over 500 stores in Australia, and employs over 20,000 staff. The company brands itself as offering discounted prices for pharmaceutical goods.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Fort Worth, Texas. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

References

  1. "Sigma Healthcare Limited". ASX. Australian Stock Exchange. Retrieved 6 September 2022.
  2. "Sigma Healthcare Limited". DnB. 31 January 2021. Retrieved 15 March 2022.
  3. "Introducing Sigma Healthcare limited". ASX. Retrieved 3 May 2017.
  4. Rose, Derek (11 December 2023). "Chemist Warehouse to land on ASX via merger with Sigma". The New Daily. Retrieved 11 December 2023.
  5. "Sigma offloads drugs arm for $900m". SMH. 16 August 2010. Retrieved 16 March 2022.
  6. "Sigma Healthcare seeks more acquisitions". Nine. 31 March 2014. Retrieved 16 March 2022.
  7. "Sigma extends retail brands with DDS acquisition for $26.7 mn". Sydney Sun. 8 September 2014. Retrieved 8 September 2014.
  8. "Sigma boss urges consultation over lockdowns, eyes opportunities". SMH. 10 August 2020. Retrieved 16 March 2022.
  9. "Sigma launches rival bid". ABC News. ABC. 27 September 2021. Retrieved 16 March 2022.
  10. "Sigma drops bid for rival API, leaving Wesfarmers to take control". Australian Financial Review. AFR. 5 November 2020. Retrieved 16 March 2022.
  11. "Australia's Wesfarmers moves to block Sigma attempt to buy API". Reuters. Reuters. 6 October 2021. Retrieved 16 March 2022.
  12. "Wesfarmers' proposed acquisition of API not opposed". ACCC. Retrieved 16 March 2022.
  13. "Amcal and Guardian to Join Forces". Retail Pharmacy. Retail Media. 27 September 2022. Retrieved 25 November 2022.
  14. "Positioned for sustainable growth". investorcentre.sigmahealthcare.com.au. Retrieved 25 May 2023.
  15. Greenblat, Eli (7 April 2010). "ASX slaps Sigma with 'please explain' order". The Sydney Morning Herald. Retrieved 15 December 2020.
  16. Symons, David (25 March 2010). "Subdued Seven eyes licence fee rebates". The Age.
  17. "The Australian". Archived from the original on 21 June 2014. Retrieved 17 January 2013.
  18. Symons, David (3 March 2010). "Picture looks bleak for Telstra". The Sydney Morning Herald.